For endometrial cancers and their primary lesions, HMGA2 showed an important role in their evaluation, as HMGA2 expression gradually increased from precancerous lesion endometrial glandular dysplasia to intraepithelial serous endometrial carcinoma and eventually to fully developed endometrial serous carcinoma [58]. This evidence concerns the gene HMGA2 and endometrial cancer.